ResMed PE Ratio 2006-2019 | RMD

Current and historical p/e ratio for ResMed (RMD) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ResMed PE ratio as of February 28, 2020 is 40.88.
ResMed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-02-28 158.96 50.62
2019-12-31 154.97 $3.14 49.35
2019-09-30 135.11 $2.90 46.59
2019-06-30 122.03 $2.80 43.58
2019-03-31 103.97 $3.08 33.76
2018-12-31 113.43 $3.11 36.47
2018-09-30 114.50 $2.32 49.35
2018-06-30 102.47 $2.19 46.79
2018-03-31 97.07 $2.14 45.36
2017-12-31 83.17 $2.00 41.59
2017-09-30 75.26 $2.47 30.47
2017-06-30 75.78 $2.41 31.45
2017-03-31 69.70 $2.29 30.44
2016-12-31 59.81 $2.30 26.00
2016-09-30 62.09 $2.40 25.87
2016-06-30 60.31 $2.43 24.82
2016-03-31 54.86 $2.45 22.39
2015-12-31 50.68 $2.46 20.60
2015-09-30 47.85 $2.46 19.45
2015-06-30 52.64 $2.47 21.31
2015-03-31 66.71 $2.47 27.01
2014-12-31 51.87 $2.46 21.09
2014-09-30 45.34 $2.42 18.74
2014-06-30 46.34 $2.40 19.31
2014-03-31 40.71 $2.29 17.78
2013-12-31 42.65 $2.24 19.04
2013-09-30 47.62 $2.17 21.94
2013-06-30 40.48 $2.10 19.28
2013-03-31 41.44 $2.13 19.46
2012-12-31 37.01 $1.99 18.60
2012-09-30 35.88 $1.88 19.08
2012-06-30 27.54 $1.72 16.01
2012-03-31 27.28 $1.56 17.49
2011-12-31 22.42 $1.46 15.36
2011-09-30 25.41 $1.41 18.02
2011-06-30 27.32 $1.44 18.97
2011-03-31 26.48 $1.41 18.78
2010-12-31 30.58 $1.39 22.08
2010-09-30 28.96 $1.32 22.02
2010-06-30 26.84 $1.23 21.82
2010-03-31 28.09 $1.19 23.71
2009-12-31 23.07 $1.13 20.51
2009-09-30 19.95 $1.05 19.09
2009-06-30 17.98 $0.95 18.92
2009-03-31 15.60 $0.85 18.46
2008-12-31 16.54 $0.78 21.21
2008-09-30 18.98 $0.73 26.00
2008-06-30 15.77 $0.71 22.37
2008-03-31 18.62 $0.69 26.98
2007-12-31 23.18 $0.40 57.96
2007-09-30 18.92 $0.42 45.59
2007-06-30 18.21 $0.42 43.36
2007-03-31 22.23 $0.40 56.28
2006-12-31 21.72 $0.67 32.67
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.532B $2.607B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $139.646B 24.44
Medtronic (MDT) Ireland $135.351B 18.19
Stryker (SYK) United States $72.986B 23.59
Boston Scientific (BSX) United States $52.944B 23.85
Baxter (BAX) United States $43.025B 26.09
Lonza Group Ag (LZAGY) Switzerland $30.160B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.680B 0.00
Coloplast (CLPBY) Denmark $29.333B 45.27
Zimmer Biomet Holdings (ZBH) United States $28.886B 17.78
Terumo (TRUMY) Japan $24.016B 29.97
Smith & Nephew SNATS (SNN) United Kingdom $20.258B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.551B 706.73
Bio-Rad Laboratories (BIO) United States $10.800B 50.46
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Perrigo (PRGO) Ireland $7.053B 12.86
Hill-Rom Holdings (HRC) United States $6.647B 19.12
DiaSorin S.p.A (DSRLF) Italy $6.446B 0.00
Canopy Growth (CGC) Canada $6.442B 0.00
Haemonetics (HAE) United States $5.501B 33.86
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.142B 27.18
Envista Holdings (NVST) United States $4.140B 0.00
NuVasive (NUVA) United States $3.433B 26.54
Neogen (NEOG) United States $3.353B 55.81
Quidel (QDEL) United States $3.229B 28.35
GW Pharmaceuticals (GWPH) United Kingdom $3.227B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.121B 0.00
Agios Pharmaceuticals (AGIO) United States $3.055B 0.00
National Vision Holdings (EYE) United States $2.822B 47.54
Aurora Cannabis (ACB) Canada $1.695B 0.00
AtriCure (ATRC) United States $1.602B 0.00
Cardiovascular Systems (CSII) United States $1.335B 0.00
NanoString Technologies (NSTG) United States $1.282B 0.00
TG Therapeutics (TGTX) United States $1.235B 0.00
InMode (INMD) Israel $1.053B 0.00
Phibro Animal Health (PAHC) United States $1.038B 20.54
Aphria (APHA) $0.934B 0.00
VAREX IMAGING (VREX) United States $0.909B 18.88
PetIQ (PETQ) United States $0.899B 21.94
Cerus (CERS) United States $0.840B 0.00
Quanterix (QTRX) United States $0.665B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.662B 126.31
Eagle Pharmaceuticals (EGRX) United States $0.642B 24.57
Lantheus Holdings (LNTH) United States $0.614B 13.96
LeMaitre Vascular (LMAT) United States $0.594B 33.79
Omeros (OMER) United States $0.591B 0.00
MacroGenics (MGNX) United States $0.496B 0.00
Surmodics (SRDX) United States $0.481B 55.34
Zynex (ZYXI) United States $0.390B 42.57
Owens & Minor (OMI) United States $0.385B 14.26
OraSure Technologies (OSUR) United States $0.370B 46.15
Organigram Holdings (OGI) Canada $0.363B 0.00
Repro-Med Systems (KRMD) United States $0.356B 225.00
Meridian Bioscience (VIVO) United States $0.349B 14.07
HEXO (HEXO) $0.335B 0.00
Utah Medical Products (UTMD) United States $0.335B 23.82
BioLife Solutions (BLFS) United States $0.298B 121.58
Evolus (EOLS) United States $0.288B 0.00
Female Health (VERU) United States $0.278B 0.00
Bovie Medical (APYX) United States $0.226B 0.00
InfuSystems Holdings (INFU) United States $0.206B 1037.00
Vapotherm (VAPO) United States $0.193B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.191B 0.00
Viemed Healthcare (VMD) United States $0.190B 20.00
Rockwell Medical (RMTI) United States $0.187B 0.00
United Health Products (UEEC) United States $0.176B 0.00
Cytosorbents (CTSO) United States $0.170B 0.00
Fonar (FONR) United States $0.132B 9.58
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.107B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
United-Guardian (UG) United States $0.074B 18.60
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
Nephros (NEPH) United States $0.066B 0.00
FSD PHARMA INC (HUGE) Canada $0.040B 0.00
NF Energy Saving (BIMI) China $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
Trinity Biotech (TRIB) Ireland $0.026B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Myomo (MYO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00